Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease

被引:5
作者
Williams, Adam N. [1 ,2 ,3 ]
机构
[1] Bend Mem Clin, Dept Allergy Asthma & Immunol, 815 Southwest Bond St, Bend, OR 97702 USA
[2] Oregon Hlth & Sci Univ, Sch Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA
[3] Bend Mem Clin, 815 Southwest Bond St, Bend, OR 97702 USA
关键词
Aspirin-exacerbated respiratory disease; Diagnosis; NSAID hypersensitivity; Chronic rhinosinusitis with nasal polyps; Asthma; Intranasal ketorolac; Oral aspirin challenge; Lysine-aspirin; PERIPHERAL-BLOOD LEUKOCYTES; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LEUKOTRIENE-MODIFIER DRUGS; NASAL PROVOCATION TEST; IN-VITRO DIAGNOSIS; INDUCED ASTHMA; SENSITIVE ASTHMATICS; BASOPHIL ACTIVATION; CYSTEINYL LEUKOTRIENES; LYSINE-ASPIRIN;
D O I
10.1016/j.iac.2016.06.003
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Aspirin-exacerbated respiratory disease (AERD) is a distinct clinical condition characterized by chronic sinusitis with nasal polyps, asthma, and hypersensitivity reactions to nonsteroidal anti-inflammatory drugs (NSAIDs). Distinguishing AERD from other forms of chronic sinusitis, asthma, and NSAID reactivity has important clinical implications for management. The clinical history is helpful, but not adequate for confirming the diagnosis of AERD, in most cases. Diagnostic provocation challenge remains the only way to confirm or exclude the diagnosis of AERD. This article discusses the utility of the clinical history and the current evidence regarding measures that optimize the safety of performing diagnostic NSAID provocation challenges.
引用
收藏
页码:657 / +
页数:14
相关论文
共 41 条
[1]   Nasal provocation test (NPT) with aspirin:: a sensitive and safe method to diagnose aspirin-induced asthma (AIA) [J].
Alonso-Llamazares, A ;
Martinez-Cócera, C ;
Domínguez-Ortega, J ;
Robledo-Echarren, T ;
Cimarra-Alvarez, M ;
del Castillo, MM .
ALLERGY, 2002, 57 (07) :632-635
[2]   Cellular Allergen Stimulation Test with Acetylsalicylic Acid-Lysine Is Not a Useful Test to Discriminate between Asthmatic Patients with and without Acetylsalicylic Acid Sensitivity [J].
Bavbek, Sevim ;
Dursun, A. Berna ;
Birben, Esra ;
Kalayci, Oemer ;
Misirligil, Zeynep .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2009, 149 (01) :58-64
[3]   The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions [J].
Berges-Gimeno, MP ;
Simon, RA ;
Stevenson, DD .
CLINICAL AND EXPERIMENTAL ALLERGY, 2002, 32 (10) :1491-1496
[4]  
Bianco S, 1977, J MED SCI, V5, P129
[5]   Aspirin-Exacerbated Respiratory Disease: Clinical Disease and Diagnosis [J].
Bochenek, Grazyna ;
Nizankowska-Mogilnicka, Ewa .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2013, 33 (02) :147-+
[6]   Release of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E2 on this release from peripheral blood leucocytes in aspirin-induced asthmatic patients [J].
Çelik, G ;
Bavbek, S ;
Misirligil, Z ;
Melli, M .
CLINICAL AND EXPERIMENTAL ALLERGY, 2001, 31 (10) :1615-1622
[7]   Use of nasal inspiratory flow rates in the measurement of aspirin-induced respiratory reactions [J].
Celikel, Serhat ;
Stevenson, Donald ;
Erkorkmaz, Unal ;
White, Andrew A. .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (04) :252-255
[8]   An Hourly Dose-Escalation Desensitization Protocol for Aspirin-Exacerbated Respiratory Disease [J].
Chen, Justin R. ;
Buchmiller, Brett L. ;
Khan, David A. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2015, 3 (06) :926-+
[9]  
DAHLEN B, 1990, EUR RESPIR J, V3, P527
[10]   Management of anaphylaxis: a systematic review [J].
Dhami, S. ;
Panesar, S. S. ;
Roberts, G. ;
Muraro, A. ;
Worm, M. ;
Bilo, M. B. ;
Cardona, V. ;
Dubois, A. E. J. ;
DunnGalvin, A. ;
Eigenmann, P. ;
Fernandez-Rivas, M. ;
Halken, S. ;
Lack, G. ;
Niggemann, B. ;
Rueff, F. ;
Santos, A. F. ;
Vlieg-Boerstra, B. ;
Zolkipli, Z. Q. ;
Sheikh, A. .
ALLERGY, 2014, 69 (02) :168-175